Studying co-medication patterns: The impact of definitions

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 4, 2007, Pages 405-411

  Tobi, Hilde ^a,b   Faber, Adrianne ^a,c   Van den Berg, Paul B ^a   Drane, Wanzer J ^d   De Jong van den Berg, Lolkje T W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c SIR Institute for Pharmacy Practice and Policy   (Netherlands)

^d EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Co medication; Combination; Drug combinations; Drug therapy; Polypharmacy; Research methodology

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; PENICILLIN G;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CHILD; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION; FEASIBILITY STUDIES; HISTAMINE H1 ANTAGONISTS; HUMANS; MIDDLE AGED; NETHERLANDS; PENICILLINS; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PRESCRIPTIONS, DRUG; TERMINOLOGY; TIME FACTORS;

EID: 34247490576     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1304     Document Type: Article

References (18)

1. Schubert I, Ihle P, Köster I, von Ferber L. Markers to analyse the prescribing of non-steroidal anti-inflammatory drugs in ambulatory care. Eur J Clin Pharmacol 1999; 55: 479-486.
2. Safer DJ, Zito JM, dosReis S. Concomitant psychotropic medication for youths. Am J Psychiatry 2003; 160: 438-449.
3. Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004; 161: 1324-1333.
4. Oxford English Dictionary. Oxford University Press, 2nd edn. 1989. [Accessed June 28, 20051. http://dictionary.oed.com.
5. Tobi H, van den Berg PB, de Jong-van den Berg LTW. The InterAction database: synergy of science and practice in pharmacy. Lect Notes Comput Sci 2000; 1933: 206-211.
6. WHO Collaborating Centre for Drugs Statistics Methodology. [Accessed April 19, 2005] http://www.whocc.no/atcddd/.
7. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled Trials. Am J Psychiatry 2004; 161: 1537-1547.
8. Silverstone PH, Silverstone T. A review of acute treatments for bipolar depression. Int J Clin Psychopharmacol 2004; 19: 113-124.
9. Romano A, Mondino C, Viola M, Montuschi P. Immediate allergic reactions to beta-lactams: diagnosis and therapy. Int J Immunopathol Pharmacol 2003; 16: 19-23.
10. Tobi H, van den Berg PB, de Jong-van den Berg LTW. Small proportions: what to report for confidence intervals? PD Saf 2005; 14: 239-247.
11. Martin A, van Hoof T, Stubbe D, Sherwin T, Scahill L. Multiple psychotropic pharmacotherapy among children and adolescent enrollees in Connecticut medicaid managed care. Psychiatric Services 2003; 53: 72-77.
12. Faber A, de Jong-van den Berg LTW, van den Berg PB, Tobi H. Psychotropic co-medication among stimulant-treated children in The Netherlands. J Child Adolesc Psychopharmacol 2005. 15: 38-43.
13. Leslie DL, Rosenheck RA. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system. Med Care 2001; 39: 923-933.
14. de Vries TW, Tobi H, Schirm E, van den Berg P, Duiverman EJ, de Jong-van den Berg LT. The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands. Eur J Clin Pharmacol 2006; 62: 51-55.
15. Koro CE, Bowlin SJ, Weiss SR. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication. PD Saf 2005; 14: 697-703.
16. Gerrits CMJM, Herings RMC, Leufkens HGM, Lammers JWJ. N-Acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 795-798.
17. Florentinus SR, Heerdink ER, de Boer A, van Dijk L, Leufkens HGM. The trade-off between cardiovascular and gastrointestinal effects of rofecoxib. PD Saf 2005; 14: 437-441.
18. Faber A, Kalverdijk LJ, de Jong-van den Berg LTW, Hugtenburg JG, Mindema RB, Tobi H. Parents report on stimulant-treated children in The Netherlands: initiation of treatment and follow-up care. J Child Adolesc Psychopharmacol. (in press).